- Home
- RGP vs LENZ Comparison
RGP vs LENZ Comparison
Compare RGP & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGP | LENZ |
|---|---|---|
| Founded | 1996 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.7M | 106.8M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGP | LENZ |
|---|---|---|
| Price | $2.71 | $3.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $6.50 | ★ $20.00 |
| AVG Volume (30 Days) | 473.9K | ★ 913.5K |
| Earning Date | 10-07-2026 | 10-28-2026 |
| Dividend Yield | ★ 9.86% | N/A |
| EPS Growth | ★ 79.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $452,006,000.00 | $19,088,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.19 | $124.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.33 | $3.00 |
| 52 Week High | $5.37 | $32.13 |
Technical Indicators
Market Signals| Indicator | RGP | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.22 | 37.62 |
| Support Level | $2.33 | N/A |
| Resistance Level | $3.86 | $6.11 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 73.15 | 23.26 |
Price Performance
Historical ComparisonAbout RGP Resources Connection Inc.
Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.